ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,392 | +82.1% | 96,824 | +455.8% | 0.00% | – |
| Q2 2022 | $9,000 | -64.0% | 17,422 | -58.2% | 0.00% | – |
| Q4 2021 | $25,000 | -50.0% | 41,716 | -18.9% | 0.00% | – |
| Q3 2021 | $50,000 | +284.6% | 51,452 | +351.3% | 0.00% | – |
| Q2 2021 | $13,000 | -58.1% | 11,400 | -64.2% | 0.00% | – |
| Q1 2021 | $31,000 | +93.8% | 31,846 | +57.0% | 0.00% | – |
| Q3 2020 | $16,000 | -20.0% | 20,279 | -45.3% | 0.00% | – |
| Q2 2020 | $20,000 | +66.7% | 37,080 | +118.3% | 0.00% | – |
| Q4 2019 | $12,000 | -61.3% | 16,989 | +23.6% | 0.00% | – |
| Q4 2018 | $31,000 | -38.0% | 13,740 | +28.6% | 0.00% | -100.0% |
| Q3 2014 | $50,000 | -37.5% | 10,681 | -35.8% | 0.00% | 0.0% |
| Q2 2014 | $80,000 | -22.3% | 16,646 | +2.8% | 0.00% | 0.0% |
| Q1 2014 | $103,000 | – | 16,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |